TAK

Takeda Pharmaceutical Company Limited
D

TAK

15.085
USD
-0.12
(-0.79%)
مفتوح الان
حجم التداول
20,758
الربح لكل سهم
134
العائد الربحي
2.15
P/E
34
حجم السوق
47,120,654,331
أصول ذات صلة
AZN
AZN
-0.605
(-0.81%)
73.740 USD
BMY
BMY
-1.180
(-2.37%)
48.580 USD
GILD
GILD
0.450
(0.41%)
110.460 USD
GSK
GSK
-0.270
(-0.66%)
40.570 USD
JNJ
JNJ
-2.120
(-1.35%)
154.910 USD
LLY
LLY
-1.34
(-0.16%)
817.51 USD
MRK
MRK
-1.050
(-1.28%)
80.650 USD
NVO
NVO
-2.640
(-3.31%)
77.215 USD
NVS
NVS
-0.795
(-0.67%)
118.640 USD
PFE
PFE
-0.165
(-0.67%)
24.355 USD
SNY
SNY
-0.190
(-0.38%)
49.470 USD
المزيد
الأخبار المقالات

العنوان: Takeda Pharmaceutical Company Limited

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.